Bond Biosciences

Bond Biosciences

Biotechnology

Parkville, Missouri
Website
Company Tagline

Discovering and developing first-in-class non-absorbed oral therapeutics to prevent and treat ion-related human diseases

Industry Category
Biotechnology
Company Description

Bond Biosciences is a dynamic biotechnology company dedicated to discovering and developing innovative, first-in-class oral therapeutics. Bond Biosciences focuses on creating non-absorbed treatments designed to prevent and treat ion-related human diseases. With a commitment to addressing unmet medical needs, Bond Biosciences is advancing novel solutions for patient care.

Located at 170 English Landing Dr, Suite 201B, Parkville, Missouri 64152, US, Bond Biosciences is strategically positioned to leverage cutting-edge research and development in the biopharmaceutical sector. Bond Biosciences aims to improve patient outcomes and quality of life through targeted therapeutic interventions.

Bond Biosciences is poised for significant growth and commercial development within the biotechnology landscape. We invite the manager of Bond Biosciences to create a customized and exclusive company showcase and product listing on our platform, to further enhance visibility and market reach.

Key Personnel / Employees
Danny Griffin Dexter Pearson Cory Berkland

Similar Companies

Other organizations in the same industry

Dioseve
Biotechnology

creating human eggs from iPS cells

Bunkyo-ku, Tokyo
Japan
DTU Bioengineering
Biotechnology

Engineering a sustainable and healthy future from the molecules of life.

EnerGaia Co., Ltd.
Biotechnology
Suanluang, Bangkok
Thailand
Shimadzu Scientific Instruments
Biotechnology

Providing innovative, proven products for a wide range of laboratories and applications

Columbia, MD
United States

Alternative Company Names

This company is also known as

Bond Biosciences 邦德生物科学 बॉन्ड बायोसाइंसेस بوند بيوساينسز Бонд Бионауки